Medicine Grand Rounds - Dr. Robert "Chip" Schooley

Academic,
Conference,
Grand Rounds,
Lecture/Seminar
Back to the Future: Bacteriophage Therapy for Multidrug Resistant Bacterial Infections
-

505 Parnassus Ave
HSW-300
San Francisco, CA 94143
United States

View on Map

Robert T. Schooley, MD is a graduate of the Johns Hopkins University School of Medicine.  He completed an internal medicine residency at the JDr. Robert "Chip" Schooleyohns Hopkins Hospital and infectious disease fellowships at the National Institute of Allergy and Infectious Diseases and the Massachusetts General Hospital.  He joined the faculty of Harvard Medical School in 1981 and shifted his research focus from herpesgroup viruses as recognition of the AIDS epidemic developed.  His early research efforts were directed at the definition of the role of HIV-1 specific cellular immune responses in the immunopathogenesis of HIV-1 infection.  He also became heavily involved in both preclinical and clinical antiretroviral chemotherapeutic research. 

He was recruited to the University of Colorado in 1990 as Head of the Division of Infectious Diseases where he developed an integrated HIV program clinical care and research program.  He was elected Chair of the NIAID’s AIDS Clinical Trials Group (ACTG) in 1995 and led that group until 2002 during which time the ACTG performed many of the seminal studies that defined modern antiretroviral chemotherapy.  He also served as Chair of the NIH ARRA Study Section and as a member of the DHHS Task Force for AIDS Drug Development Task Force.  He also served as the founding Chair of the Conference on Retroviruses and Opportunistic Infections (CROI).

In 2005, he joined the faculty at the University of California, San Diego where he currently serves as Head of the Division of Infectious Diseases, Vice Chair of the Department of Medicine and Senior Director for International Initiatives for UC San Diego. He also serves as Editor-in-Chief of Clinical Infectious Diseases. His research interests are in the diagnosis, pathogenesis and therapy of viral infections and in global health. More recently, he has become interested in the use of viruses as therapeutic agents – namely the use of bacteriophages to treat multidrug resistant bacterial infections.

To access MGR live streams and current semester recordings, please visit ETS here: DOM Medical Grand Rounds.